Managers / Q4 2024 · view latest →
Vestal Point Capital, LP
CIK 0001974915 · 632 BROADWAY, SUITE 602, NEW YORK, NY, 10012 · 6469894000
Reported Value
$1.7B
Q4 2024
Positions
73
Filings on Record
10
2019–present window
Filed
Feb 14, 2025
original filing
Summary
Vestal Point Capital, Lp reported $1.7B in U.S.-listed holdings across 73 positions for Q4 2024.
Its largest position, Jazz Pharmaceuticals, represents 7.1% of the portfolio.
Compared with Q3 2024, the fund opened 25 new positions and exited 21.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 65.4% · $1.1B
- Other · 22.7% · $383M
- ADR · 11.9% · $201M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q4 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $3.6B | 90 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $2.9B | 76 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $2.2B | 81 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.9B | 72 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.4B | 63 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.7B | 73 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.3B | 69 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.3B | 60 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.2B | 58 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $944M | 48 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.